![M. Harris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Harris
Corporate Officer/Principal at
Middleburg Consultants, Inc.
Profile
M.
Scott Harris was the founder of Lyric Pharmaceuticals, Inc., founded in 2013, where the title held was Chief Medical Officer from 2013 to 2018.
Current jobs include Principal at Middleburg Consultants, Inc. and Professor at Georgetown University School of Medicine.
Former jobs include Chief Medical Officer & VP-Clinical Affairs at Napo Pharmaceuticals, Inc., Chief Medical Officer at Avaxia Biologics, Inc., Chief Medical Officer at OCERA Therapeutics LLC, Chief Medical Officer at Tranzyme Pharma, Inc. (Canada), and Chief Medical Officer at Altimmune, Inc. from 2019 to 2025.
Education includes a doctorate from Harvard Medical School and graduate studies at the University of Wisconsin School of Medicine & Public Health.
M. Harris active positions
| Companies | Position | Start |
|---|---|---|
Middleburg Consultants, Inc. | Corporate Officer/Principal | - |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of M. Harris
| Companies | Position | End |
|---|---|---|
| ALTIMMUNE, INC. | Chief Tech/Sci/R&D Officer | 2025-09-30 |
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel gastrointestinal therapeutics | Founder | 2018-04-30 |
| OCERA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | - |
Tranzyme Pharma, Inc. (Canada) | Chief Tech/Sci/R&D Officer | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Chief Tech/Sci/R&D Officer | - |
Training of M. Harris
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel gastrointestinal therapeutics | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tranzyme Pharma, Inc. (Canada) | |
Middleburg Consultants, Inc. | |
Georgetown University School of Medicine
Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin School of Medicine & Public Health
 University of Wisconsin School of Medicine & Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- M. Harris
